{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04069",
      "entity_text" : "NEP inhibitor",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P02810",
      "entity_text" : "PA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Here we show for the first time that co-injection of a NEP inhibitor (phosphoramidon (PA)) can lead to an impressive enhancement of diagnostic sensitivity and therapeutic efficacy of the theranostic 68 Ga-/ 177 Lu-JMV4168 GRPR-antagonist.",
  "reading_complete" : "2020-08-02T12:00:37Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T11:59:08Z",
  "trigger" : "lead",
  "evidence" : [ "NEP inhibitor (phosphoramidon (PA)) can lead" ],
  "pmc_id" : "4679358",
  "score" : 0
}